aPROMISE: a novel automated PROMISE platform to standardize evaluation of tumor burden in 18F-DCFPyL images of veterans with prostate cancer

N Nickols, A Anand, K Johnsson… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Standardized staging and quantitative reporting are necessary to demonstrate the
association of 18F-DCFPyL PET/CT imaging with clinical outcome. This work introduces an …

Potential impact of 68Ga-PSMA-11 PET/CT on the planning of definitive radiation therapy for prostate cancer

J Calais, AU Kishan, M Cao, WP Fendler… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Standard-of-care imaging for initial staging of prostate cancer (PCa) underestimates disease
burden. Prostate-specific membrane antigen (PSMA) PET/CT detects PCa metastasis with …

[HTML][HTML] Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized …

K Johnsson, J Brynolfsson, H Sahlstedt… - European Journal of …, 2022 - Springer
Purpose The application of automated image analyses could improve and facilitate
standardization and consistency of quantification in [18F] DCFPyL (PSMA) PET/CT scans. In …

Detection rate of 18F-rhPSMA-7.3 PET in patients with suspected prostate cancer recurrence: Results from a phase 3, prospective, multicenter study (SPOTLIGHT)

DM Schuster, SPOTLIGHT Study Group - 2022 - ascopubs.org
9 Background: 18F-labeled prostate-specific membrane antigen (PSMA) positron emission
tomography (PET) ligands offer a longer half-life and improved spatial resolution compared …

Comparison of 3 interpretation criteria for 68Ga-PSMA11 PET based on inter-and intrareader agreement

A Toriihara, T Nobashi, L Baratto, H Duan… - Journal of Nuclear …, 2020 - Soc Nuclear Med
PET using radiolabeled prostate-specific membrane antigen (PSMA) is now being more
widely adopted as a valuable tool to evaluate patients with prostate cancer (PC). Recently, 3 …

Matched-pair comparison of 18F-DCFPyL PET/CT and 18F-PSMA-1007 PET/CT in 240 prostate cancer patients: interreader agreement and lesion detection rate of …

M Wondergem, FM van der Zant… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Over 20 different prostate-specific membrane antigen (PSMA)–targeting
radiopharmaceuticals for both imaging and therapy have been synthesized. Although …

[HTML][HTML] Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer

MCF Cysouw, BHE Jansen, T van de Brug… - European journal of …, 2021 - Springer
Purpose Quantitative prostate-specific membrane antigen (PSMA) PET analysis may
provide for non-invasive and objective risk stratification of primary prostate cancer (PCa) …

18F-DCFPyL PET/CT for primary staging in 160 high-risk prostate cancer patients; metastasis detection rate, influence on clinical management and preliminary …

M Wondergem, FM Van Der Zant, WAM Broos… - European Journal of …, 2021 - Springer
Purpose Prostate-specific membrane antigen (PSMA) PET/CT shows better diagnostic
performance for detection of lymph node and bone metastases as compared to conventional …

[HTML][HTML] Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in …

K Subramanian, J Martinez… - Scientific Reports, 2023 - nature.com
Prostate cancer (PC) staging with conventional imaging often includes multiparametric
magnetic resonance (MR) of the prostate, computed tomography (CT) of the chest …

[HTML][HTML] Freely Available, Fully Automated AI-Based Analysis of Primary Tumour and Metastases of Prostate Cancer in Whole-Body [18F]-PSMA-1007 PET-CT

E Trägårdh, O Enqvist, J Ulén, J Jögi, U Bitzén… - Diagnostics, 2022 - mdpi.com
Here, we aimed to develop and validate a fully automated artificial intelligence (AI)-based
method for the detection and quantification of suspected prostate tumour/local recurrence …